慢性肾脏病患者心血管疾病认识的最新进展
Recent Advances in Understanding of Cardiovascular Diseases in Patients with Chronic Kidney Disease.
作者信息
Krisanapan Pajaree, Pattharanitima Pattharawin, Thongprayoon Charat, Cheungpasitporn Wisit
机构信息
Department of Internal Medicine, Division of Nephrology, Faculty of Medicine, Thammasat University, Pathum Thani 12120, Thailand.
Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
出版信息
J Clin Med. 2022 Aug 9;11(16):4653. doi: 10.3390/jcm11164653.
Abstract
Chronic kidney disease (CKD) is a major public health problem, affecting between 8% and 16% of the population worldwide [...].
摘要
慢性肾脏病（CKD）是一个重大的公共卫生问题，影响着全球8%至16%的人口[...]。
相似文献
1
Recent Advances in Understanding of Cardiovascular Diseases in Patients with Chronic Kidney Disease.慢性肾脏病患者心血管疾病认识的最新进展
J Clin Med. 2022 Aug 9;11(16):4653. doi: 10.3390/jcm11164653.
2
Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes.慢性肾脏病作为一个全球公共卫生问题：应对方法与倡议——改善全球肾脏病预后组织的立场声明
Kidney Int. 2007 Aug;72(3):247-59. doi: 10.1038/sj.ki.5002343. Epub 2007 Jun 13.
3
[Chronic kidney disease: novelties and scope of follow-up by the primary care physician].[慢性肾脏病：初级保健医生随访的新进展与范围]
Nefrologia. 2008;28 Suppl 5:113-7.
4
Mild to moderate chronic kidney disease and cardiovascular events in patients with type 2 diabetes mellitus.2型糖尿病患者的轻度至中度慢性肾脏病与心血管事件
Vasc Health Risk Manag. 2019 Aug 22;15:365-373. doi: 10.2147/VHRM.S203925. eCollection 2019.
5
Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.非酒精性脂肪性肝病与慢性肾脏病的临床转归。
Nephrol Dial Transplant. 2019 Mar 1;34(3):449-457. doi: 10.1093/ndt/gfx381.
6
Update on fibroblast growth factor 23 in chronic kidney disease.慢性肾脏病中成纤维细胞生长因子 23 的最新研究进展。
Kidney Int. 2012 Oct;82(7):737-47. doi: 10.1038/ki.2012.176. Epub 2012 May 23.
7
Cardiovascular complications of chronic renal failure - an updated review.慢性肾衰竭的心血管并发症——最新综述
Mymensingh Med J. 2012 Jul;21(3):573-9.
8
Chronic kidney disease in Spain: Prevalence and impact of accumulation of cardiovascular risk factors.西班牙的慢性肾脏病：心血管危险因素累积的患病率及影响
Nefrologia (Engl Ed). 2018 Nov-Dec;38(6):606-615. doi: 10.1016/j.nefro.2018.04.004. Epub 2018 Jun 18.
9
Molecular mechanisms in renal degenerative disease.肾脏退行性疾病的分子机制。
Semin Cell Dev Biol. 2010 Oct;21(8):831-7. doi: 10.1016/j.semcdb.2010.08.010. Epub 2010 Sep 15.
10
CKD in China: Evolving Spectrum and Public Health Implications.中国的慢性肾脏病：不断变化的疾病谱与公共卫生影响。
Am J Kidney Dis. 2020 Aug;76(2):258-264. doi: 10.1053/j.ajkd.2019.05.032. Epub 2019 Sep 3.
引用本文的文献
1
Disease Progression Modeling of Estimated Glomerular Filtration Rate (eGFR): A Pharmacometrics Approach.估计肾小球滤过率（eGFR）的疾病进展建模：一种药代动力学方法。
J Diabetes. 2025 Jun;17(6):e70104. doi: 10.1111/1753-0407.70104.
2
A practical guide for nephrologist peer reviewers: understanding and appraising Mendelian randomization studies.肾科同行评审员实用指南：理解和评估孟德尔随机化研究
Ren Fail. 2025 Dec;47(1):2445763. doi: 10.1080/0886022X.2024.2445763. Epub 2025 Jan 13.
3
Potential Nephroprotective Effect of Kaempferol: Biosynthesis, Mechanisms of Action, and Clinical Prospects.山奈酚的潜在肾保护作用：生物合成、作用机制及临床前景
Adv Pharmacol Pharm Sci. 2024 Sep 30;2024:8907717. doi: 10.1155/2024/8907717. eCollection 2024.
4
From bytes to nephrons: AI's journey in diabetic kidney disease.从字节到肾单位：人工智能在糖尿病肾病中的征程。
J Nephrol. 2025 Jan;38(1):25-35. doi: 10.1007/s40620-024-02050-2. Epub 2024 Aug 12.
5
Chronic Kidney Disease Associated with Ischemic Heart Disease: To What Extent Do Biomarkers Help?与缺血性心脏病相关的慢性肾脏病：生物标志物有多大帮助？
Life (Basel). 2023 Dec 25;14(1):34. doi: 10.3390/life14010034.
6
Sodium Thiosulfate for Calciphylaxis Treatment in Patients on Peritoneal Dialysis: A Systematic Review.硫代硫酸钠治疗腹膜透析患者钙化防御：系统评价。
Medicina (Kaunas). 2023 Jul 14;59(7):1306. doi: 10.3390/medicina59071306.
7
Revolutionizing Chronic Kidney Disease Management with Machine Learning and Artificial Intelligence.利用机器学习和人工智能革新慢性肾脏病管理
J Clin Med. 2023 Apr 21;12(8):3018. doi: 10.3390/jcm12083018.
8
Outcomes of Acute Coronary Syndrome Patients Who Presented with Cardiogenic Shock versus Patients Who Developed Cardiogenic Shock during Hospitalization.因心源性休克就诊的急性冠状动脉综合征患者与住院期间发生心源性休克的患者的结局。
J Clin Med. 2023 Mar 30;12(7):2603. doi: 10.3390/jcm12072603.
本文引用的文献
1
Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.慢性肾脏病中的心血管疾病：病理生理学见解与治疗选择。
Circulation. 2021 Mar 16;143(11):1157-1172. doi: 10.1161/CIRCULATIONAHA.120.050686. Epub 2021 Mar 15.
2
Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy.慢性肾脏病心房颤动患者的血栓栓塞和出血风险：抗凝治疗的作用
J Clin Med. 2020 Dec 28;10(1):83. doi: 10.3390/jcm10010083.
3
Contemporary National Outcomes of Acute Myocardial Infarction-Cardiogenic Shock in Patients with Prior Chronic Kidney Disease and End-Stage Renal Disease.既往慢性肾脏病和终末期肾病患者急性心肌梗死合并心源性休克的当代全国性结局
J Clin Med. 2020 Nov 18;9(11):3702. doi: 10.3390/jcm9113702.
4
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的心房颤动诊断和管理指南：欧洲心脏病学会（ESC）心房颤动诊断和管理特别工作组，由ESC欧洲心律协会（EHRA）特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
5
Endothelial Dysfunction in Chronic Kidney Disease, from Biology to Clinical Outcomes: A 2020 Update.慢性肾脏病中的内皮功能障碍：从生物学机制到临床结局——2020年更新
J Clin Med. 2020 Jul 23;9(8):2359. doi: 10.3390/jcm9082359.
6
Low Plasma Lecithin: Cholesterol Acyltransferase (LCAT) Concentration Predicts Chronic Kidney Disease.低血浆卵磷脂：胆固醇酰基转移酶（LCAT）浓度可预测慢性肾脏病。
J Clin Med. 2020 Jul 18;9(7):2289. doi: 10.3390/jcm9072289.
7
Calciprotein Particles and Serum Calcification Propensity: Hallmarks of Vascular Calcifications in Patients with Chronic Kidney Disease.钙蛋白颗粒与血清钙化倾向：慢性肾脏病患者血管钙化的特征
J Clin Med. 2020 Apr 29;9(5):1287. doi: 10.3390/jcm9051287.
8
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家慢性肾脏病负担，1990-2017 年：2017 年全球疾病负担研究的系统分析。
Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.
9
Clustering Heatmap for Visualizing and Exploring Complex and High-dimensional Data Related to Chronic Kidney Disease.用于可视化和探索与慢性肾脏病相关的复杂高维数据的聚类热图
J Clin Med. 2020 Feb 2;9(2):403. doi: 10.3390/jcm9020403.
10
Association of Trimethylamine, Trimethylamine N-oxide, and Dimethylamine with Cardiovascular Risk in Children with Chronic Kidney Disease.三甲胺、氧化三甲胺和二甲胺与慢性肾脏病儿童心血管风险的关联
J Clin Med. 2020 Jan 25;9(2):336. doi: 10.3390/jcm9020336.
Zotero 插件